France Gene Editing Technology Business and Investment Opportunities 2023: A $532.2 Million Market by 2027
28 juin 2023 04h08 HE
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "France Gene Editing Technology Databook 2023" has been added to ResearchAndMarkets.com's offering.France's gene editing technology market is forecast...
Nucleic Acid Isolation and Purification Market is Expected to Reach $9.2 Billion | MarketsandMarkets.
19 juin 2023 09h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, June 19, 2023 (GLOBE NEWSWIRE) -- The nucleic acid isolation and purification industry is poised for remarkable growth and innovation in the near future. With the increasing demand for...
UAE Gene Editing Technology Databook 2023: Compound Annual Growth of 8.4% Forecast During 2023-2027
13 juin 2023 04h03 HE
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "UAE Gene Editing Technology Databook 2023" has been added to ResearchAndMarkets.com's offering.The UAE gene editing technology market is expected to...
Bacterial and Plasmid Vectors Global Market Report 2023: Increasing Prevalence of Cancer and Infectious Diseases Drives Growth
09 juin 2023 09h38 HE
|
Research and Markets
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Bacterial And Plasmid Vectors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
VaxEquity and CPI Announces Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics
05 juin 2023 03h00 HE
|
VaxEquity
CAMBRIDGE, United Kingdom, June 05, 2023 (GLOBE NEWSWIRE) -- VaxEquity, developing transformative RNA vaccines and therapeutics based on its next generation self-amplifying RNA (saRNA) platform, and...
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
30 mai 2023 07h01 HE
|
GreenLight Biosciences
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive...
NGS-Based RNA-sequencing Markets: Sample Preparation, Platforms & Consumables, Services, Data Analysis, De Novo, Epigenetics, Small RNA - Global Forecast to 2027
26 mai 2023 07h23 HE
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "NGS-Based RNA-sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS,...
FDA Grants SiSaf’s Innovative siRNA Therapy SIS-101-ADO Orphan Drug Designation and Rare Pediatric Disease Designation for the Treatment of Autosomal Dominant Osteopetrosis
15 mai 2023 03h00 HE
|
SiSaf Ltd
GUILDFORD, England, May 15, 2023 (GLOBE NEWSWIRE) -- SiSaf Ltd, an RNA delivery and therapeutics company, announces that SIS-101-ADO, its siRNA therapeutic for patients with Autosomal Dominant...
RNA Therapeutics Markets, 2035 - Technical and Financial Perspective on How the Opportunity in this Domain is Likely to Evolve
24 avr. 2023 03h33 HE
|
Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Investor Series: Opportunities in RNA Therapeutics Market" report has been added to ResearchAndMarkets.com's offering. The Investor Series:...
Global NGS-Based RNA-Sequencing Market Report 2023: Growth in Precision Medicine is Fuelling the Sector
18 avr. 2023 12h13 HE
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "NGS-Based RNA-Sequencing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...